EUVIMEDSkopri EUVIMED
Übersichtsarbeit

Small fiber neuropathy

Josef Finsterer, Fulvio A Scorza

Acta Neurologica Scandinavica · 2022-05 · 145 (5) · 493-503

DOI: 10.1111/ane.13591 ↗

At a glance

Übersichtsarbeit in Acta Neurologica Scandinavica, published online on 2022-02-07. Written by Josef Finsterer and 1 co-authors. Institution: Neurology & Neurophysiology Center, Vienna, Austria. Major MEDLINE topics: Peripheral Nervous System Diseases, Small Fiber Neuropathy. Cited 38 times so far (Crossref); 80 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Small fiber neuropathy (SFN) is a peripheral nervous system disease due to affection of A-delta or C-fibers in a proximal, distal, or diffuse distribution. Selective SFN (without large fiber affection) manifests with pain, sensory disturbances, or autonomic dysfunction. Though uniform diagnostic criteria are unavailable, most of them request typical clinical features and reduced intra-epidermal nerve fiber density on proximal or distal skin biopsy. Little consensus has been reached about the treatment of SFN, why this narrative review aims at summarizing and discussing treatment options for SFN. Treatment of SFN can be classified as symptomatic, pathophysiologic, or causal. Prerequisites for treating SFN are an established diagnosis, knowledge about the symptoms and signs, and the etiology. Pain usually responds to oral/intravenous pain killers, antidepressants, anti-seizure drugs, or topical, transdermal specifications. Some of the autonomic disturbances respond favorably to symptomatic treatment. SFN related to Fabry disease or hATTR are accessible to pathogenesis-related therapy. Immune-mediated SFN responds to immunosuppression or immune-modulation. Several of the secondary SFNs respond to causal treatment of the underlying disorder. In conclusion, treatment of SFN relies on a multimodal concept and includes causative, pathophysiologic, and symptomatic measures. It strongly depends on the clinical presentation, diagnosis, and etiology, why it is crucial before initiation of treatment to fix the diagnosis and etiology. Due to the heterogeneous clinical presentation and multi-causality, treatment of SFN should be individualized with the goal of controlling the underlying cause, alleviating pain, and optimizing functionality.

Subjects

MeSH terms (MEDLINE)

Peripheral Nervous System DiseasesSmall Fiber NeuropathyBiopsyHumansPainSkin

Author keywords

autonomic dysfunctionoutcomepainsmall fiber neuropathytreatment

Authors and institutions

  • Neurology & Neurophysiology Center, Vienna, Austria.
  • Disciplina de Neurociência, Escola Paulista de Medicina/Universidade Federal de São Paulo/. (EPM/UNIFESP), São Paulo, Brasil.

Cite

APA

Finsterer, J., & Scorza, F. A. (2022). Small fiber neuropathy. Acta Neurologica Scandinavica, 145(5), 493-503. https://doi.org/10.1111/ane.13591

Vancouver

Finsterer J, Scorza FA. Small fiber neuropathy. Acta Neurologica Scandinavica. 2022;145(5):493-503. doi:10.1111/ane.13591

BibTeX
@article{Finsterer2022,
  author = {Finsterer, Josef and Scorza, Fulvio A},
  title = {Small fiber neuropathy},
  journal = {Acta Neurologica Scandinavica},
  year = {2022},
  volume = {145},
  number = {5},
  pages = {493--503},
  doi = {10.1111/ane.13591}
}
Start for free →